PCSK9 Inhibitor Evolocumab Not Associated with Decline in Memory or Cognitive Function

Research finds no association between the use of the PCSK9 inhibitor evolocumab& a decline in memory or cognitive function.

Source: BWH for Journalists - March 18, 2017 Category: Research Source Type: news